FR2324304B2 - - Google Patents

Info

Publication number
FR2324304B2
FR2324304B2 FR7528939A FR7528939A FR2324304B2 FR 2324304 B2 FR2324304 B2 FR 2324304B2 FR 7528939 A FR7528939 A FR 7528939A FR 7528939 A FR7528939 A FR 7528939A FR 2324304 B2 FR2324304 B2 FR 2324304B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7528939A
Other languages
French (fr)
Other versions
FR2324304A2 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7528939A priority Critical patent/FR2324304A2/en
Publication of FR2324304A2 publication Critical patent/FR2324304A2/en
Application granted granted Critical
Publication of FR2324304B2 publication Critical patent/FR2324304B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
FR7528939A 1975-09-22 1975-09-22 Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine Granted FR2324304A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7528939A FR2324304A2 (en) 1975-09-22 1975-09-22 Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7528939A FR2324304A2 (en) 1975-09-22 1975-09-22 Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine

Publications (2)

Publication Number Publication Date
FR2324304A2 FR2324304A2 (en) 1977-04-15
FR2324304B2 true FR2324304B2 (en) 1978-09-01

Family

ID=9160268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7528939A Granted FR2324304A2 (en) 1975-09-22 1975-09-22 Analgesic (4)-hydroxy-quinoline-(3)-amides - prepd. from a quinoline-(3)-carboxyl chloride and an amine

Country Status (1)

Country Link
FR (1) FR2324304A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8829204B2 (en) 2004-06-24 2014-09-09 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2443467A1 (en) * 1978-12-08 1980-07-04 Roussel Uclaf NOVEL 3-QUINOLEINE CARBOXYLIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENT
HU190796B (en) * 1981-06-12 1986-11-28 Roussel Uclaf,Fr Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
FR2507602A1 (en) * 1981-06-12 1982-12-17 Roussel Uclaf N-4,5-di:hydro-2-thiazolyl 4-hydroxy 3-quinoline-carboxamide derivs. - anxiolytics having strong affinity for benzodiazepine receptors, opt. used in association with neuroleptics or antidepressants
US4786644A (en) * 1987-11-27 1988-11-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinolinecarboxamide
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
EP2408750B1 (en) 2009-03-20 2015-08-26 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
CA2865519C (en) 2012-02-27 2018-01-02 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions comprising a solid dispersion of n-[2,4-bis(1,1-dimethylethyl0-5-hydroxyphenyl-1]-1,4-dihydro-4-oxoquinolone-3-carboxamide for treating cystic fibrosis
MX370450B (en) 2014-10-07 2019-12-13 Vertex Pharma Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8829204B2 (en) 2004-06-24 2014-09-09 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8410274B2 (en) 2005-12-28 2013-04-02 Vertex Pharmaceuticals Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US8754224B2 (en) 2005-12-28 2014-06-17 Vertex Pharmaceuticals Incorporated Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Also Published As

Publication number Publication date
FR2324304A2 (en) 1977-04-15

Similar Documents

Publication Publication Date Title
FR2324304B2 (en)
JPS5237858U (en)
JPS5433794Y2 (en)
JPS5190104A (en)
JPS54115Y2 (en)
JPS544838B2 (en)
JPS5227120U (en)
JPS5247867U (en)
JPS5616456Y2 (en)
JPS5611609B2 (en)
JPS5273654U (en)
JPS51106288U (en)
JPS51147635U (en)
JPS51112476U (en)
CS176011B1 (en)
JPS5222889U (en)
JPS51131143U (en)
CH604615A5 (en)
CH602904A5 (en)
BG22905A1 (en)
BG22517A1 (en)
LU75916A1 (en)
CH1429075A4 (en)
CH611381A5 (en)
CH601015A5 (en)